Wilson Disease: Update on Pathophysiology and Treatment

Area of Science:

• Genetics and Molecular Biology
• Hepatology
• Biochemistry

Background:

• Wilson disease (WD) is a severe genetic disorder characterized by copper overload, primarily in the liver.
• Established causes involve ATP7B gene mutations and hepatic copper accumulation, but these do not fully explain the varied clinical presentations.
• Recent studies indicate a broader role for non-parenchymal liver cells and extrahepatic tissues in WD pathogenesis.

Purpose of the Study:

• To review recent advancements in understanding Wilson disease pathophysiology.
• To discuss emerging molecular details and metabolic signatures associated with WD phenotypes.
• To identify and discuss novel diagnostic and therapeutic targets for Wilson disease.

Main Methods:

• Literature review of recent studies on Wilson disease.
• Analysis of molecular mechanisms, including ATP7B function, copper transport, and cellular dysfunction.
• Examination of findings from WD patient studies and animal models.

Main Results:

• Dysregulation of nuclear receptors (NR), epigenetic modifications, and mitochondrial dysfunction are identified as key hallmarks of WD pathogenesis.
• Non-parenchymal liver cells and extrahepatic tissues contribute significantly to the liver phenotype in WD.
• Emerging evidence points to specific metabolic signatures correlating with different WD phenotypes.

Conclusions:

• A comprehensive understanding of WD pathophysiology requires considering cellular and systemic factors beyond simple hepatic copper levels.
• Novel therapeutic strategies may target nuclear receptors, epigenetic pathways, or mitochondrial function.
• Further research into metabolic signatures could improve WD diagnosis and personalized treatment approaches.